Amarantus Bioscience Holdings Inc (AMBS)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Amarantus Bioscience Holdings Total Liabilities (Quarterly): 31.57M for March 31, 2018
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2018 | 31.57M |
| March 31, 2016 | 37.69M |
| December 31, 2015 | 20.46M |
| September 30, 2015 | 16.18M |
| June 30, 2015 | 7.973M |
| March 31, 2015 | 7.628M |
| December 31, 2014 | 6.329M |
| September 30, 2014 | 3.389M |
| June 30, 2014 | 3.599M |
| March 31, 2014 | 4.312M |
| December 31, 2013 | 9.378M |
| September 30, 2013 | 5.504M |
| June 30, 2013 | 5.576M |
| March 31, 2013 | 6.166M |
| December 31, 2012 | 4.738M |
| September 30, 2012 | 4.615M |
| June 30, 2012 | 4.452M |
| March 31, 2012 | 3.936M |
| Date | Value |
|---|---|
| December 31, 2011 | 3.705M |
| September 30, 2011 | 3.102M |
| June 30, 2011 | 2.720M |
| April 30, 2011 | 0.1197M |
| January 31, 2011 | 0.1057M |
| October 31, 2010 | 0.0781M |
| July 31, 2010 | 0.0629M |
| April 30, 2010 | 0.044M |
| January 31, 2010 | 0.0206M |
| October 31, 2009 | 0.0202M |
| July 31, 2009 | 0.0125M |
| April 30, 2009 | 0.0104M |
| January 31, 2009 | 0.0046M |
| October 31, 2008 | 0.0075M |
| July 31, 2008 | 0.00 |
| April 30, 2008 | 0.0005M |
| January 31, 2008 | 0.001M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.18M |
| Shareholders Equity (Quarterly) | -21.39M |